advertisement
Neural Regeneration Research 55
Showing records 1 to 25 | Display all abstracts in Neural Regeneration Research118787 Global trends in diabetic eye disease research from 2012 to 2021
Yuan Y
Neural Regeneration Research 2024; 19: 2310-2320
117397 The concept of gene therapy for glaucoma: the dream that has not come true yet
Sulak R
Neural Regeneration Research 2024; 19: 92-99
117503 Morphological disruption and visual tuning alterations in the primary visual cortex in glaucoma (DBA/2J) mice
Yang Y
Neural Regeneration Research 2024; 19: 220-225
117659 Retinoprotective compounds, current efficacy, and future prospective
Marino R
Neural Regeneration Research 2023; 18: 2619-2622
118784 Age-related driving mechanisms of retinal diseases and neuroprotection by transcription factor EB-targeted therapy
Abokyi S
Neural Regeneration Research 2025; 20: 366-377
117534 p38 MAPK inhibitor SB202190 suppresses ferroptosis in the glutamate-induced retinal excitotoxicity glaucoma model
Feng L
Neural Regeneration Research 2024; 19: 2299-2309
117668 The roles of macrophage migration inhibitory factor in retinal diseases
Zhang H
Neural Regeneration Research 2024; 19: 309-315
117426 Cell replacement with stem cell-derived retinal ganglion cells from different protocols
Luo Z
Neural Regeneration Research 2024; 19: 807-810
117568 Annexin A1 in the nervous and ocular systems
Wang A
Neural Regeneration Research 2024; 19: 591-597
118450 Casein kinase-2 inhibition promotes retinal ganglion cell survival after acute intraocular pressure elevation
Wang M; Yao SQ
Neural Regeneration Research 2024; 19: 1112-1118
117397 The concept of gene therapy for glaucoma: the dream that has not come true yet
Liu X
Neural Regeneration Research 2024; 19: 92-99
117426 Cell replacement with stem cell-derived retinal ganglion cells from different protocols
Chang KC
Neural Regeneration Research 2024; 19: 807-810
117503 Morphological disruption and visual tuning alterations in the primary visual cortex in glaucoma (DBA/2J) mice
Yang Z
Neural Regeneration Research 2024; 19: 220-225
117659 Retinoprotective compounds, current efficacy, and future prospective
Sappington R
Neural Regeneration Research 2023; 18: 2619-2622
118784 Age-related driving mechanisms of retinal diseases and neuroprotection by transcription factor EB-targeted therapy
Tse DY
Neural Regeneration Research 2025; 20: 366-377
117668 The roles of macrophage migration inhibitory factor in retinal diseases
Zhang X
Neural Regeneration Research 2024; 19: 309-315
117568 Annexin A1 in the nervous and ocular systems
Zhang H
Neural Regeneration Research 2024; 19: 591-597
118787 Global trends in diabetic eye disease research from 2012 to 2021
Ji S
Neural Regeneration Research 2024; 19: 2310-2320
117534 p38 MAPK inhibitor SB202190 suppresses ferroptosis in the glutamate-induced retinal excitotoxicity glaucoma model
Wang C; Zhang C
Neural Regeneration Research 2024; 19: 2299-2309
117568 Annexin A1 in the nervous and ocular systems
Li X
Neural Regeneration Research 2024; 19: 591-597
118787 Global trends in diabetic eye disease research from 2012 to 2021
Song Y
Neural Regeneration Research 2024; 19: 2310-2320
117668 The roles of macrophage migration inhibitory factor in retinal diseases
Li H
Neural Regeneration Research 2024; 19: 309-315
117397 The concept of gene therapy for glaucoma: the dream that has not come true yet
Smedowski A
Neural Regeneration Research 2024; 19: 92-99
118450 Casein kinase-2 inhibition promotes retinal ganglion cell survival after acute intraocular pressure elevation
Huang Y
Neural Regeneration Research 2024; 19: 1112-1118
117503 Morphological disruption and visual tuning alterations in the primary visual cortex in glaucoma (DBA/2J) mice
Lv M
Neural Regeneration Research 2024; 19: 220-225
